• This record comes from PubMed

Genetic variation associated with chromosomal aberration frequency: A genome-wide association study

. 2019 Jan ; 60 (1) : 17-28. [epub] 20181003

Language English Country United States Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

Chromosomal aberrations (CAs) in human peripheral blood lymphocytes (PBL) measured with the conventional cytogenetic assay have been used for human biomonitoring of genotoxic exposure for decades. CA frequency in peripheral blood is a marker of cancer susceptibility. Previous studies have shown associations between genetic variants in metabolic pathway, DNA repair and major mitotic checkpoint genes and CAs. We conducted a genome-wide association study on 576 individuals from the Czech Republic and Slovakia followed by a replication in two different sample sets of 482 (replication 1) and 1288 (replication 2) samples. To have a broad look at the genetic susceptibility associated with CA frequency, the sample sets composed of individuals either differentially exposed to smoking, occupational/environmental hazards, or they were untreated cancer patients. Phenotypes were divided into chromosome- and chromatid-type aberrations (CSAs and CTAs, respectively) and total chromosomal aberrations (CAtot). The arbitrary cutoff point between individuals with high and low CA frequency was 2% for CAtot and 1% for CSA and CTA. The data were analyzed using age, sex, occupation/cancer and smoking history as covariates. Altogether 11 loci reached the P-value of 10-5 in the GWAS. Replication 1 supported the association of rs1383997 (8q13.3) and rs2824215 (21q21.1) in CAtot and rs983889 (5p15.1) in CTA analysis. These loci were found to be associated with genes involved in mitosis, response to environmental and chemical factors and genes involved in syndromes linked to chromosomal abnormalities. Identification of new genetic variants for the frequency of CAs offers prediction tools for cancer risk in future. Environ. Mol. Mutagen. 60:17-28, 2019. © 2018 Wiley Periodicals, Inc.

Biomedical Centre Faculty of Medicine in Pilsen Charles University Prague Pilsen Czech Republic

Center of Primary Health Care Research Clinical Research Center Lund University 20502 Malmö Sweden

Clinic of Occupational Medicine and Toxicology Jessenius Faculty of Medicine in Martin Comenius University in Bratislava and University Hospital Martin Kollarova 2 03601 Martin Slovakia

Department of Biology Faculty of Medicine Slovak Medical University Limbova 12 833 03 Bratislava Slovakia

Department of Genomics Life and Brain Center University of Bonn D 53127 Bonn Germany

Department of Medical Genetics 3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Molecular Biology of Cancer Institute of Experimental Medicine The Czech Academy of Sciences Videnska 1083 142 00 Prague Czech Republic

Department of Molecular Genetic Epidemiology German Cancer Research Center Im Neuenheimer Feld 580 69120 Heidelberg Germany

Department of Molecular Oncology Cancer Research Institute Biomedical Research Center Slovak Academy of Sciences Dubravska cesta 9 84505 Bratislava Slovakia

Division of Medical Genetics Department of Biomedicine University of Basel 4003 Basel Switzerland

Health Effects Laboratory Department of Environmental Chemistry NILU Norwegian Institute for Air Research Instituttveien 18 2007 Kjeller Norway

Institute of Biology and Medical Genetics 1st Faculty of Medicine Charles University Albertov 4 128 00 Prague Czech Republic

Institute of Human Genetics University of Bonn D 53127 Bonn Germany

Medizinische Fakultät Universität Heidelberg Im Neuenheimer Feld 672 69120 Heidelberg

References provided by Crossref.org

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...